Monoclonal antibodies

Lucid Diligence Brief - BioPharma

Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief

Vedana Therapeutics has emerged from stealth with $46 million in Series A…

by Eugenia Tsempera

Vaccines

Vaccines Today—April 30, 2026

This weekly update in Vaccines Research highlights recent regulatory actions,…

by LucidQuest

Respiratory

Respiratory Today—January 9, 2026

This respiratory update spotlights reflects strong momentum across respiratory…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in Alzheimer's

Lucid Diligence Brief: Sanofi and ADEL sign global licensing deal in…

by Timos Papagatsias

Immunology

Immunology Video Recap—December 3, 2025

This biweekly immunology video highlights major regulatory wins, evolving…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.